Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)

Launched by ANKARA ETLIK CITY HOSPITAL · Dec 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a method called the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) to help manage pain after breast cancer surgery, specifically modified radical mastectomy. The goal is to see how effective this technique is in reducing pain and opioid use after the surgery. SPSIPB is a type of nerve block that can provide targeted pain relief by delivering a local anesthetic to specific areas around the spine, which can help patients feel more comfortable during recovery.

To participate in this trial, individuals need to be between 18 and 80 years old and have a body mass index (BMI) within a certain range (between 18 and 40). Eligible participants will have undergone a single-level or two-level SPSIPB along with their mastectomy. The trial is not yet recruiting, but once it begins, participants can expect to receive the SPSIPB during their surgery, which aims to reduce postoperative pain and potentially lower the need for stronger pain medications. This trial is important because it may offer a safer and more effective way to manage pain after breast cancer surgery, improving the overall recovery experience for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1-Those between the ages of 18-80
• • 2.Those with ASA score I-II-III
• • 3.Those with body mass index (BMI) between 18-40
• • 4.Patients who underwent Single-Level or Two-Level SPSIPB together with mastectomy in the operating room
• Exclusion Criteria:
• • 1. Those under 18 and over 80
• • 2. Those with ASA score IV and above
• • 3. Those with advanced co-morbidities
• • 4. Those with a history of bleeding diathesis
• • 5. Patients with infection in the area where the block will be performed
• • 6. Those with BMI under 18 and over 40
• • 7. Patients who underwent surgery under emergency conditions